Ethylene

Ethylene

SCHEMBL5155337

C=C.CCOC(C)OCC.O=CCBr

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188914 0.95 LMNA (0.60) LMNATHRB
Ethylene Glycol SCHEMBL5988402 0.92 LMNA (0.46) LMNA
Butane SCHEMBL11232709 0.91 LMNA (0.55) LMNATHRB
SCHEMBL7927646 0.87 LMNA (0.50) LMNA
Ethylene SCHEMBL11209176 0.85 LMNA (0.48) LMNA
Acetaldehyde SCHEMBL22361219 0.83 LMNA (0.63) LMNATHRB
Ethylene SCHEMBL5712219 0.82 LMNA (0.55) LMNATHRB
Ethylene SCHEMBL5964966 0.81 LMNA (0.48) LMNA
Propionaldehyde SCHEMBL1523503 0.80 LMNA (0.67) LMNATHRB
Glutaral SCHEMBL6229345 0.80 LMNA (0.52) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117949577-A Method for detecting genotoxic impurities in doxofylline 北京阳光诺和药物研究股份有限公司 2024-04-30 CN claimed
CN-215540985-U Honeycomb duct for preparing bromoacetaldehyde ethylene acetal 淄博齐风川润化工有限公司 2022-01-18 CN claimed
CN-214810928-U Bromo acetaldehyde shrinkage ethylene glycol is with heat preservation reation kettle 淄博齐风川润化工有限公司 2021-11-23 CN claimed
CN-108326470-B Environment-friendly water cleaning type soldering flux 五河县俊宝钢结构有限公司 2020-12-04 CN claimed
CN-211190203-U A heat preservation reation kettle for bromo acetaldehyde ethylene acetal 淄博齐风川润化工有限公司 2020-08-07 CN claimed
CN-110921957-A Rubber accelerator production wastewater treatment process 镇江苏秦环保科技有限公司 2020-03-27 CN claimed
CN-107880808-B Preparation method of composite glass flame-retardant interlayer gel 蚌埠承永玻璃制品有限公司 2019-12-20 CN claimed
CN-120025316-A Compound for targeted degradation of ALK protein, and preparation method and application thereof 成都分迪药业有限公司 2025-05-23 CN disclosed
CN-118206854-B High-strength plastic for automotive interior parts and preparation method thereof 爱卓智能科技(常州)有限公司 2024-11-15 CN disclosed
CN-118206854-A High-strength plastic for automotive interior parts and preparation method thereof 爱卓智能科技(常州)有限公司 2024-06-18 CN disclosed
CN-117949577-A Method for detecting genotoxic impurities in doxofylline 北京阳光诺和药物研究股份有限公司 2024-04-30 CN disclosed
CN-114213398-B Preparation method of polysubstituted furan derivative, bactericide and application 湖北省生物农药工程研究中心 2024-04-16 CN disclosed
CN-111484510-B Preparation method of (2, 6-trimethyl-1-cyclohexenyl) aldehyde 新发药业有限公司 2023-02-03 CN disclosed
US-6358958-B2 MONO OR BICYCLIC ARYL OR HETERARYL SUBSTITUTED PIPERIZIN DERIVATIVES USEFUL FOR TREATING ANXIETY, DEPRESSION, HYPERTENSION, COGNITIVE DISORDER, PSYCHOSIS, SLEEP DISORDER, BRAIN TRAUMA, MEMORY LOSS, DRUG ABUSE, MIGRAINE AND OBESITY ELI LILLY AND COMPANY 2002-03-19 US disclosed
US-20010003749-A1 Mono or bicyclic aryl or heteraryl substituted piperizin derivatives useful for treating anxiety, depression, hypertension, cognitive disorder, psychosis, sleep disorder, brain trauma, memory loss, drug abuse, migraine and obesity GODFREY ALEXANDER GLENN (US) 2001-06-14 US disclosed
US-6239135-B1 ALLEVIATING THE SYMPTOMS OF NICOTINE AND TOBACCO WITHDRAWAL. ELI LILLY AND COMPANY 2001-05-29 US disclosed
WO-2001035964-A1 SUBSTITUTED 1-BENZAZEPINES AND DERIVATIVES THEREOF ANTEXPHARMA, INC. (US) 2001-05-25 WO disclosed
WO-1999031077-A1 ARYLPIPERAZINES HAVING ACTIVITY AT THE SEROTONIN 1A RECEPTOR ELI LILLY AND COMPANY (US) 1999-06-24 WO disclosed
EP-0924205-A1 Arylpiperazines having activity at the serotonin 1a receptor ELI LILLY AND COMPANY (US) 1999-06-23 EP disclosed
US-5817875-A Methods for the manufacture of terbinafine KARIMIAN KHASHAYAR (CA) 1998-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010003749-A1 Mono or bicyclic aryl or heteraryl substituted piperizin derivatives useful for treating anxiety, depression, hypertension, cognitive disorder, psychosis, sleep disorder, brain trauma, memory loss, drug abuse, migraine and obesity HTR1A, HTR2C, HTR3B LMNA 1376/4885THRB 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.